Skip to main content
Signal8
Woods Lori A profile photo

Lori A. Woods

CIK: 0001393007

Transaction Breakdown

Open Market Buys (P)1 (33.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Perspective Therapeutics, Inc. logo
CATX

Perspective Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Perspective Therapeutics, Inc. logo
    CATX

    Perspective Therapeutics, Inc.

    Mar 2, 2026
    Award(A)

    Stock option (right to buy)

    Direct
    50K shares-
  • Perspective Therapeutics, Inc. logo
    CATX

    Perspective Therapeutics, Inc.

    Mar 31, 2025
    Purchase(P)
    Indirect
    23.5K shares at avg. $2.13$50K
  • Perspective Therapeutics, Inc. logo
    CATX

    Perspective Therapeutics, Inc.

    Mar 3, 2025
    Award(A)

    Stock option (right to buy)

    Direct
    50K shares-

1-3 of 3

About Woods Lori A

Woods Lori A (SEC CIK 0001393007) files insider reports with the SEC as Director of Perspective Therapeutics, Inc. (CATX).

Signal8 holds 3 ownership filings by Woods Lori A, all Form 4s, filed between Mar 5, 2025 and Mar 4, 2026. Those filings report 3 transactions, from Mar 3, 2025 to Mar 2, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Woods Lori A's filings is in SEATTLE, WA.

Recent filings by Woods Lori A

  • Mar 2, 2026: Grant or award of CATX derivative securities (Form 4, code A).
  • Mar 31, 2025: Open-market purchase of CATX shares (Form 4, code P).
  • Mar 3, 2025: Grant or award of CATX derivative securities (Form 4, code A).

Other insiders filing for Perspective Therapeutics, Inc. (CATX)

How to read Form 4 transaction codes